Porphyrinuric action of drugs related to sulphanilamide. Comparison with reported toxicity, therapeutic efficiency and causation of methaemoglobinaemia. Definition of the structure responsible for porphyrinuric action

被引：37

作者：

Rimington, C ^{[1
]}

Hemmings, AW ^{[1
]}

机构：

[1] Natl Inst Med Res, London, England

来源：

关键词：

D O I：

10.1042/bj0330960

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：960 / 977

页数：18

共 43 条

[1] CLINE, 1938, JAMA-J AM MED ASSOC, V111, P2384
[2] de Langen CD, 1938, ACTA MED SCAND, V94, P245
[3] DUESBERG, 1933, ARCH EXP PATHOL PH, V174, P305
[4] ELLINGER, 1920, HOPPESEYL Z, V111, P86
[5] ESPERSEN, 1937, UGESKR LOEG, V99, P993
[6] Feinstone WH, 1938, B JOHNS HOPKINS HOSP, V62, P565
[7] Fuller AT, 1937, LANCET, V1, P194
[8] Garvin CF, 1938, J AMER MED ASSOC, V111, P2283, DOI 10.1001/jama.1938.02790510031007
[9] Hageman PO, 1937, P SOC EXP BIOL MED, V37, P119
[10] A study of some of the physiological effects of sulfanilamide II Methemoglobin formation and its control
Hartmann, AF
Perley, AM
Barnett, HL
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1938, 17 (06) : 699 - 710